Table 1 Study population.
From: Urothelial cancer proteomics provides both prognostic and functional information
Urothelial tumors | |
|---|---|
Number of patients | 58 |
Age (years) | |
≤60 | 20(34,5%) |
>60 | 38(65,5%) |
Median(IQR) | 68(60–71) |
Range | 45–78 |
Sex | |
Male | 51(88%) |
Female | 7(12%) |
pT category | |
pT2a | 2(3.5%) |
pT2b | 10(17.3%) |
pT3a | 27(46.5%) |
pT3b | 8(13.8%) |
pT4a | 9(15.5%) |
pT4b | 1(1.7%) |
Missing | 1(1.7%) |
pN category | |
pN0 | 32(55%) |
pN1 | 14(24%) |
pN2 | 6(10%) |
Missing | 6(10%) |
Highest G grade | |
G1-2 | 8(14%) |
G3 | 44(76%) |
